Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01650506
Title Study of Erlotinib and Metformin in Triple Negative Breast Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Matthew A. Maurer
Indications

breast cancer

Therapies

Erlotinib + Metformin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.